experience the triple play
of CONVENIENCE, QUALITY,
AND INNOVATION
Baxter's Ready-to-Use Premixes: Designed for
Today's Healthcare Needs
Innovative Products for Every Need
At Pharmaceuticals at Baxter, innovation means creating solutions that adapt to your demands. Our ready-to-use premixes streamline operations with:
- A broad portfolio of options tailored to specific patient needs
- Proprietary technologies like our closed-system GALAXY container for enhanced stability
- A commitment to versatility, offering frozen and liquid premixes that support various care environments
Prioritizing Patient Care
Every dose matters. That’s why we put patient safety and care at the forefront with:
- Sterile, closed-system formulations to reduce contamination risk 2,6
- FDA-approved, barcoded premixes to help with accurate bedside administration 1
- Compliance with ASHP and ISMP guidelines, helping you minimize medication errors associated with using commercially available products 1,2
Efficiency That Elevates Your Team
Your focus should be on patients—not compounding tasks. Baxter premixes help simplify workflows by:
- Reducing preparation steps and saving critical time 3
- Freeing up resources to help manage staffing challenges and focus on care 4,7
- Minimizing waste and maximizing inventory management 5
Latest White Paper Now Available
Medication errors with intravenous (IV) drugs have become a global concern, and patient harm attributed to medication errors and contamination can have a significant impact on the health care system.
This white paper "Ready to Use and Ready to Administer Drugs: An important Shift Towards Safe Clinical Practice’, will provide an overview of ready to use and ready to administer drugs and their benefits to health systems, focusing on reduction of errors and contamination and operational efficiency and flexibility. To learn how your team could benefit, download your copy today.
Download White Paper
Please fill out the form below to download our latest white paper: "Ready-to-Use and Ready to Administer Drugs: An Important Shift Towards Safe Clinical Practice"
References
- Billstein-Leber M, Carrillo JD, Cassano AT, Moline K. Robertson JJ. ASHP guidelines on preventing medication errors in hospitals. Am J Health Syst Pharm. 2018;75(19):1493-1517.
- Institute for Safe Medication Practices. ISMP Guidelines for Sterile Compounding and the Safe Use of Sterile Compounding Technology: 2022. https://www.ismp.org/resources/guidelinessterile-compounding-and-safe-use-sterilecompounding-technology . Accessed July 8, 2023.
- Park J, Sang Bin You, Gi Wook Ryu, Kim Y. Attributes of errors, facilitators, and barriers related to rate control of IV medications: a scoping review. Systematic Reviews. 2023;12(1). doi:https://doi.org/10.1186/s13643-023-02386-z .
- Zhang X, Tai D, Pforsich H, Lin VW. United States registered nurse workforce report card and shortage forecast: a revisit.Am J Med Quality. 2018;33(3):229-236. doi:10.1177/1062860617738328.
- ASHP Expert Panel on Medication Cost Management. ASHP guidelines on medication cost management strategies for hospitals and health systems. Am J Health Syst Pharm. 2008;65[14]:1368-1384.
- Mercaldi CJ, Lanes S, Bradt J. Comparative risk of bloodstream infection in hospitalized patients receiving intravenous medication by open, point-of-care, or closed delivery systems. Am J Health Syst Pharm. 2013;70(11):957-965.
- Traynor K. Hospitals scramble as pharmacy technician shortage persists. Am J Health Syst Pharm. 2022 Jun 4:zxac150. doi: 10.1093/ajhp/zxac150. Epub ahead of print. PMID: 35660852.
About Us
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical, nutritional, renal, hospital and surgical care products and services. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen.
©Copyright 2025 Baxter. All rights reserved.
US-PH00-25003 (v1.0) 04/2025